Principal Investigator

Geneviève Deblois

Metabolic and Epigenetic Alterations in Cancer

Geneviève Deblois and her team aim to better understand the development of drug resistance in cancers, particularly in triple negative breast cancer. They study changes in cell metabolism that contribute to the development of resistance to treatments by modifying the epigenetic profile of cancer cells.

Full profile under construction

Principal Investigator, Metabolic and Epigenetic Alterations in Cancer Research Unit, IRIC

Assistant Professor, Faculty of Pharmacy, Université de Montréal

Metabolic and Epigenetic Alterations in Cancer Unit

Marcelle-Coutu Pavilion, 3306-15

Phone (office)
(514) 343-6111, ext. 0617
Email
genevieve.deblois@umontreal.ca

News